Trademark: 79373552
Word
LONKIRLO
Status Date
Tuesday, August 13, 2024
Filing Date
Wednesday, April 12, 2023
Published for Opposition
Tuesday, August 13, 2024
5 Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
Jan 9, 2024
Assigned To Examiner
Jul 6, 2023
Sn Assigned For Sect 66a Appl From Ib
Jul 7, 2023
New Application Office Supplied Data Entered
Jul 11, 2023
Application Filing Receipt Mailed
Jan 9, 2024
Non-Final Action Written
Jan 10, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Jan 25, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Feb 14, 2024
Refusal Processed By Ib
Jul 9, 2024
Approved For Pub - Principal Register
Jul 9, 2024
Correspondence Received In Law Office
Jul 9, 2024
Teas/Email Correspondence Entered
Jul 9, 2024
Teas Response To Office Action Received
Jul 24, 2024
Notification Of Notice Of Publication E-Mailed
Aug 13, 2024
Published For Opposition
Aug 13, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 25, 2024
Refusal Processed By Mpu
Trademark Alertz updated from USPTO on 2030-01-24